Takekuma Munetaka

Research theme for competitive and other funds (1)：

2020 - 2023 子宮頸癌に対する本邦での低侵襲手術の再発リスク因子の検証

Papers (51)：

Noriyuki Okonogi, Keisuke Tsuchida, Ken Ando, Tatsuya Ohno, Hiroyuki Fujiwara, Kosuke Yoshihara, Takuya Aoki, Hirokuni Takano, Munetaka Takekuma, Aikou Okamoto, et al. Significance of definitive concurrent chemoradiotherapy for vulvar cancer: a Japanese Gynecologic Oncology Group nationwide survey study. Japanese journal of radiology. 2024
Ayumi Taguchi, Kosuke Kato, Konan Hara, Akiko Furusawa, Yujiro Nakajima, Chihiro Ishizawa, Michihiro Tanikawa, Kenbun Sone, Mayuyo Mori, Muneaki Shimada, et al. Heterogeneous treatment effects of adjuvant therapy for patients with cervical cancer in the intermediate-risk group. Cancer Medicine. 2023
Mika Mizuno, Kimihiko Ito, Hidekatsu Nakai, Hidenori Kato, Shoji Kamiura, Kimio Ushijima, Shoji Nagao, Hirokuni Takano, Masao Okadome, Munetaka Takekuma, et al. Veliparib with frontline chemotherapy and as maintenance in Japanese women with ovarian cancer: a subanalysis of efficacy, safety, and antiemetic use in the phase 3 VELIA trial. International journal of clinical oncology. 2022. 28. 1. 163-174
Eiji Kobayashi, Eiji Nakatani, Tomohito Tanaka, Kawai Yosuke, Hiroyuki Kanao, Yasuhiko Shiki, Yasushi Kotani, Tsutomu Hoshiba, Rie Minami, Hiroshi Yoshida, et al. Surgical skill and oncological outcome of laparoscopic radical hysterectomy: JGOG1081s-A1, an ancillary analysis of the Japanese Gynecologic Oncology Group Study JGOG1081. Gynecologic oncology. 2022. 165. 2. 293-301
Shin Nishio, Koji Matsuo, Hiroki Nasu, Kenta Murotani, Yoshiki Mikami, Nobuo Yaegashi, Toyomi Satoh, Aikou Okamoto, Mitsuya Ishikawa, Tsutomu Miyamoto, et al. Analysis of postoperative adjuvant therapy in 102 patients with gastric-type mucinous carcinoma of the uterine cervix: A multi-institutional study. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2022

ｍore...

MISC (4)：

中村俊昭, 田畑務, 柳田聡, 近藤英司, 濱西潤三, 原野謙一, 長谷川幸清, 平澤猛, 堀謙輔, 小宮山慎一, et al. 前治療歴を有する高悪性度漿液性卵巣癌患者を対象としたニラパリブの国内第II相臨床試験の最終結果(The Final Results of a Japanese Phase 2 Study of Niraparib in Heavily Pretreated, HRd High-grade Serous Ovarian Cancer Patients). 日本婦人科腫瘍学会学術講演会プログラム・抄録集. 2022. 64回. 193-193
長井裕, 三上幹男, 武隈宗孝, 喜多川亮, 長尾昌二, 戸澤晃子, 西尾真, 小林栄仁, 生水真紀夫, 宮城悦子, et al. 子宮頸部腺癌に対する同時化学放射線療法に関する多施設共同調査研究. 日本産科婦人科学会雑誌. 2019. 71. 臨増. S-324
Munetaka Takekuma, Fumiaki Takahashi, Seiji Mabuchi, Wataru Kudaka, Koji Horie, Mariko Ikeda, Ayumi Shikama, Akira Mitsuhashi, Shoji Nagao, Shiro Suzuki, et al. Propensity score-matched analysis of systemic chemotherapy versus hysterectomy for patients with residual cervical disease after definitive radiotherapy/concurrent chemoradiotherapy. JOURNAL OF CLINICAL ONCOLOGY. 2018. 36. 15
野田真永, 大野達也, 馬屋原健司, 武隈宗孝, 平嶋泰之, 宮城悦子, 平田英司, 田畑勉, 青木陽一, 若月優, et al. 子宮子宮頸がんの放射線療法・化学療法局所進行子宮頸癌に対するCDDP/PTX同時併用化学放射線療法の多施設共同第II相試験. 日本癌治療学会学術集会抄録集. 2016. 54回. WS21-6

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page